Medicare Enrolled
Dr. Matin Sharafatkhah, M.D
Endocrinology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sharafatkhah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharafatkhah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharafatkhah
Dr. Matin Sharafatkhah is an endocrinology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sharafatkhah performed 3,800 Medicare services across 2,232 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharafatkhah received a total of $336,152 from 68 pharmaceutical and/or device companies across 1619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharafatkhah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in NY
$336,152 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,800
Medicare services
Top 17% in NY for endocrinology
2,232
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~190 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,316 | $113 | $216 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $79 | $156 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
507 | $13 | $25 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
259 | $101 | $200 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
167 | $109 | $208 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
157 | $7 | $10 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
120 | $46 | $69 |
| Bone density scan (DEXA) of forearm, finger, hand, or foot A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture. |
116 | $38 | $57 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
114 | $82 | $153 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
114 | $116 | $217 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
113 | $122 | $232 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
97 | $59 | $112 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $153 | $289 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $51 | $94 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
29 | $80 | $152 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $98 | $196 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
20 | $185 | $559 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$336,152
Total received (2018-2024)
Avg $48,022/year across 7 years
Top 2% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,619
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312,130 (92.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,131 (5.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,891 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,146
2023
$6,516
2022
$23,154
2021
$28,130
2020
$64,651
2019
$103,790
2018
$105,764
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$503
ABBVIE INC.
$455
Amgen Inc.
$393
Boehringer Ingelheim Pharmaceuticals, Inc.
$380
Novo Nordisk Inc
$352
Xeris Pharmaceuticals, Inc.
$275
Novartis Pharmaceuticals Corporation
$248
Lilly USA, LLC
$219
Bayer Healthcare Pharmaceuticals Inc.
$209
Abbott Laboratories
$173
CeQur Corporation
$123
IRONWOOD PHARMACEUTICALS, INC
$116
Amphastar Pharmaceuticals, Inc.
$113
E.R. Squibb & Sons, L.L.C.
$98
Esperion Therapeutics, Inc.
$87
AIMMUNE THERAPEUTICS, INC.
$64
Ardelyx, Inc.
$61
SANOFI-AVENTIS U.S. LLC
$55
AstraZeneca Pharmaceuticals LP
$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Medtronic, Inc.
$35
Exact Sciences Corporation
$28
Dexcom, Inc.
$25
Astellas Pharma US Inc
$23
Avvisto Therapeutics, LLC
$20
Top 3 companies account for 32.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$122,446
Amgen Inc.
$57,272
SANOFI-AVENTIS U.S. LLC
$50,371
Boehringer Ingelheim Pharmaceuticals, Inc.
$33,207
Lilly USA, LLC
$23,736
Amarin Pharma Inc.
$18,264
Bayer HealthCare Pharmaceuticals Inc.
$14,245
Bayer Healthcare Pharmaceuticals Inc.
$2,862
Novo Nordisk Inc
$1,713
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$943
Novartis Pharmaceuticals Corporation
$937
AbbVie Inc.
$865
ABBVIE INC.
$736
Horizon Therapeutics plc
$709
AbbVie, Inc.
$691
Allergan Inc.
$615
Corcept Therapeutics
$503
E.R. Squibb & Sons, L.L.C.
$439
Xeris Pharmaceuticals, Inc.
$390
Synergy Pharmaceuticals Inc
$320
Kowa Pharmaceuticals America, Inc.
$317
Dexcom, Inc.
$310
Merck Sharp & Dohme Corporation
$261
Esperion Therapeutics, Inc.
$248
Merck Sharp & Dohme LLC
$232
IBSA Pharma Inc.
$228
Takeda Pharmaceuticals U.S.A., Inc.
$220
Abbott Laboratories
$218
Regeneron Healthcare Solutions, Inc.
$196
Endo Pharmaceuticals Inc.
$194
Ironwood Pharmaceuticals, Inc
$190
Amneal Pharmaceuticals LLC
$158
Althera Pharmaceuticals LLC
$153
Nestle HealthCare Nutrition Inc.
$143
DEXCOM, INC.
$142
Progenics Pharmaceuticals, Inc.
$125
CeQur Corporation
$123
IRONWOOD PHARMACEUTICALS, INC
$116
Amphastar Pharmaceuticals, Inc.
$113
Radius Health, Inc.
$109
Janssen Pharmaceuticals, Inc
$99
Intra-Sana Laboratories
$86
Medtronic MiniMed, Inc.
$76
Antares Pharma, Inc.
$73
Nevro Corp.
$68
AIMMUNE THERAPEUTICS, INC.
$64
Ardelyx, Inc.
$61
Medtronic, Inc.
$49
Amryt Pharma Holdings Ltd
$44
NESTLE HEALTHCARE NUTRITION INC.
$42
Alkermes, Inc.
$37
GlaxoSmithKline, LLC.
$36
ARBOR PHARMACEUTICALS, INC.
$35
ARALEZ PHARMACEUTICALS US INC.
$29
Exact Sciences Corporation
$28
Ultragenyx Pharmaceutical Inc.
$24
Astellas Pharma US Inc
$23
Shield Therapeutics Inc
$23
Avanir Pharmaceuticals, Inc.
$22
Becton, Dickinson and Company
$21
Allergan, Inc.
$21
Avvisto Therapeutics, LLC
$20
MannKind Corporation
$20
Insulet Corporation
$19
Intuity Medical Inc
$19
Genentech USA, Inc.
$19
Shire North American Group Inc
$18
Seqirus USA Inc
$15
Top 3 companies account for 68.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · Aimovig · Amitiza · Aristada 441 mg · BAQSIMI · BD NANO · BYDUREON · CAMZYOS · CREON · CRYSViTA · CYCLOSET · CeQur Simplicity · Cologuard Collection Kit · Creon · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · Fluad · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LICART · LINZESS · LIVALO · LOKELMA · LYUMJEV · Linzess · Livalo · MINIMED 780G · MOTEGRITY · MOUNJARO · MYCAPSSA · Motegrity · NASCOBAL · NATPARA · NEXLETOL · NOCDURNA · NUEDEXTA · Omnia · Omnipod · Otezla · Ozempic · PENNSAID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PYLARIFY · Pogo Automatic Blood Glucose Monitoring System · Prolia · QULIPTA · RECORLEV · RELISTOR · RELTONE 200 MG · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYNJARDY · SYNTHROID · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tirosint · Tresiba · Trulance · Tymlos · UBRELVY · UNITHROID · VERQUVO · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · ZENPEP · ZONTIVITY · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in NY.
Geographic Context
Endocrinologists within 10 mi
635
Per 100K population
24.0
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sharafatkhah is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sharafatkhah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sharafatkhah performed 1,316 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharafatkhah receive payments from pharmaceutical companies?
Yes. Dr. Sharafatkhah received a total of $336,152 from 68 companies across 1,619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharafatkhah's costs compare to other endocrinologists in Brooklyn?
Dr. Sharafatkhah's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharafatkhah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Brooklyn
Browse endocrinologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology